Esperion TherapeuticsRecent Data Breaches and Security Report

https://esperion.com  ᛫  Biotech & Pharmaceuticals
Last updated October 26, 2018

Company Details

Company Overview

Esperion Therapeutics, Inc. is a public, American pharmaceutical company focused on the development of a first-in-class, orally available, small molecule designed to significantly lower elevated levels of LDL-C - with the reduced potential for muscle-related side effects associated with statin use.

Valuation

$1,938,391,100

Employees

CEO

Tim Mayleben

Location

Ann Arbor, MI, United States.

Recent Data Breaches

Stay informed about the most recent data breaches affecting companies like Esperion Therapeutics

subscribe to data breach notifications

Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's CSTAR Score ranges from 0 to 950. The higher the score, the more effective a company is in implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Esperion Therapeutics

Get full security report ›

See UpGuard In Action

Book a call with one of our specialists and we'll arrange a time for a demo.